Yüklüyor......
North American cost analysis of brand name versus generic drugs for the treatment of glaucoma
BACKGROUND: According to the World Health Organization, glaucoma is a leading cause of irreversible blindness worldwide. By 2020, 80 million people will be affected by glaucoma in the world, which represents a significant financial burden to society. Glaucoma medications alone make up 38–52% of the...
Kaydedildi:
| Yayımlandı: | Clinicoecon Outcomes Res |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6924989/ https://ncbi.nlm.nih.gov/pubmed/31908505 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S156558 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|